Management of Enterobacter cloacae Infection in a Tunneled Dialysis Catheter

Initial Assessment and Management

The Infectious Diseases Society of America recommends beginning parenteral antibiotic therapy immediately with coverage for gram-negative bacilli, particularly targeting Enterobacter cloacae based on local susceptibility patterns 2
Obtain paired blood cultures from the catheter and a peripheral vein before starting antibiotics to confirm catheter-related bloodstream infection (CRBSI), as recommended by the Clinical Infectious Diseases society 3, 4
Perform clinical evaluation to rule out tunnel infection, exit site infection, or other complications such as septic thrombosis, endocarditis, or metastatic infection, according to the Clinical Infectious Diseases guidelines 1
Adjust antibiotic therapy based on culture and susceptibility results once available, as suggested by the Praxis Medical Insights 2

For uncomplicated infection, attempt catheter salvage with systemic antibiotics plus antibiotic lock therapy for 14 days, as recommended by the Clinical Infectious Diseases society 1, 2
Antibiotic lock therapy should contain high concentrations of appropriate antibiotics based on susceptibility testing, according to the Clinical Infectious Diseases guidelines 1
Monitor closely with clinical evaluation and additional blood cultures; remove catheter if clinical deterioration occurs, as suggested by the Clinical Infectious Diseases society 4, 1

Prepare antibiotic lock solution with concentrations 100-1000 times higher than the minimum inhibitory concentration (MIC) for the isolated organism, as recommended by the Clinical Infectious Diseases society 1
Instill the antibiotic lock solution into the catheter lumen after each dialysis session and allow it to dwell until the next session, according to the Clinical Infectious Diseases guidelines 1
Continue antibiotic lock therapy for the full 14-day course in conjunction with systemic antibiotics, as suggested by the Clinical Infectious Diseases society 1, 2

Enterobacter species can develop resistance during therapy, particularly to third-generation cephalosporins due to inducible AmpC beta-lactamases, as noted by the Praxis Medical Insights 2
Consider carbapenems or fourth-generation cephalosporins for definitive therapy based on susceptibility results, as recommended by the Praxis Medical Insights 2

Failure to recognize tunnel infection or other complications may lead to inappropriate attempts at catheter salvage, according to the Clinical Infectious Diseases society 1
Inadequate dwell time or concentration of antibiotic lock solution reduces effectiveness, as noted by the Clinical Infectious Diseases society 1